CLPT
ClearPoint Neuro, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-28/100
Last price
10.94
▼ 0.58 (5.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.99
Prev close
11.52
Day high
11.74
Day low
10.63
Volume
904.74K
Market cap
$335.85M
P/E (TTM)
—
52W range
8.27 – 30.10
Day trading desk
Gap from prior close
-4.60%
Prior close 11.52
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
0.42%
10.94 – 10.99
Position in range
0%
Near session low
ATR (14D)
1.15
10.48% of price
Prior day high
11.53
PDH
Prior day low
10.61
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 636.10K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-6.46%
-8.4%
1M
-21.13%
-22.3%
3M
-36.32%
-40.8%
6M
+21.39%
+3.2%
YTD
-19.52%
-33.8%
1Y
-59.79%
-76.2%
3Y
+119.76%
+37.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CLPT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+77.69K
Net buying
Buy transactions
17
186.04K shares
Sell transactions
5
108.35K shares
Net transactions
+22
Buys less sells
Sell : buy shares
0.6 : 1
Mixed
Insider-held shares
1.67M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 1, 26 | FLETCHER R JOHN Director |
STOCK | 993 | $12.13K | Direct |
| Sep 2, 26 | BURNETT JOSEPH MICHAEL Chief Executive Officer |
CONVERSION | 12.52K | $43.43K | Direct |
| Jul 1, 26 | RICHARDS TIMOTHY T Director |
STOCK | 222 | $3.96K | Direct |
| Jul 1, 26 | FLETCHER R JOHN Director |
STOCK | 662 | $11.81K | Direct |
| Jun 30, 26 | BURNETT JOSEPH MICHAEL Chief Executive Officer |
STOCK | 1.36K | $24.28K | Direct |
| Jun 30, 26 | D'ALESSANDRO DANILO Chief Financial Officer |
STOCK | 1.08K | $19.36K | Direct |
| Jun 30, 26 | STIGALL L JEREMY Officer |
STOCK | 1.78K | $31.77K | Direct |
| Jun 29, 26 | BURNETT JOSEPH MICHAEL Chief Executive Officer |
CONVERSION | 20.00K | $50.00K | Direct |
| Jun 29, 26 | BURNETT JOSEPH MICHAEL Chief Executive Officer |
SELL | 20.00K | $387.60K | Direct |
| Jun 17, 26 | BURNETT JOSEPH MICHAEL Chief Executive Officer |
CONVERSION | 60.00K | $150.00K | Direct |
| Jun 17, 26 | BURNETT JOSEPH MICHAEL Chief Executive Officer |
SELL | 61.84K | $1.10M | |
| Jun 4, 26 | RICHARDS TIMOTHY T Director |
CONVERSION | 500 | $5.00K | Direct |
| Jun 1, 26 | RICHARDS TIMOTHY T Director |
SELL | 5.42K | $65.90K | Direct |
| May 21, 26 | KLEIN MATTHEW B Director |
SELL | 16.00K | $185.44K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BURNETT JOSEPH MICHAEL |
Chief Executive Officer | 322.11K | Conversion of Exercise of derivative security |
D'ALESSANDRO DANILO |
Chief Financial Officer | 103.77K | Stock Award(Grant) |
FALLON LYNNETTE C |
Director | 48.23K | Sale |
FLETCHER R JOHN |
Director | 132.00K | Stock Award(Grant) |
GIRIN PASCAL E R |
Director | 110.62K | Conversion of Exercise of derivative security |
JOHNSON B KRISTINE |
Director | 71.12K | Conversion of Exercise of derivative security |
LIAU LINDA M. |
Director | 64.80K | Conversion of Exercise of derivative security |
RICHARDS TIMOTHY T |
Director | 87.54K | Stock Award(Grant) |
SABRA MAZIN |
Chief Operating Officer | 67.34K | Conversion of Exercise of derivative security |
STIGALL L JEREMY |
Officer | 110.26K | Stock Award(Grant) |
Fundamentals
Market cap$335.85M
Enterprise value$370.43M
Revenue (TTM)$42.28M
Gross profit$26.47M
EBITDA$-28.21M
Net income$-34.57M
EPS (TTM)$-1.18
Free cash flow$-14.05M
Total cash$29.36M
Total debt$63.95M
Book value / share$0.35
Shares outstanding30.50M
Float26.28M
Short % of float14.68%
Dividend yield0.00%
Beta (5Y)1.29
Valuation & profitability ratios
Trailing P/E—
Forward P/E-9.21
PEG ratio0.61
Price / sales—
Price / book31.19
EV / revenue8.76
EV / EBITDA-13.13
Gross margin62.61%
Operating margin-94.15%
Profit margin-81.76%
Return on equity-226.52%
Return on assets-24.43%
Debt / equity593.41
Current ratio4.75
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $36.97M | $31.39M | $23.95M | $20.55M | +17.8% |
| Operating revenue | $36.97M | $31.39M | $23.95M | $20.55M | +17.8% |
| Cost of revenue | $14.28M | $12.27M | $10.34M | $7.02M | +16.4% |
| Gross profit | $22.69M | $19.12M | $13.61M | $13.53M | +18.7% |
| Research & development | $13.90M | $12.39M | $11.71M | $10.89M | +12.1% |
| Selling, general & admin | $32.96M | $26.46M | $24.35M | $18.97M | +24.5% |
| Total operating expense | $46.86M | $38.86M | $36.06M | $29.86M | +20.6% |
| Operating income | -$24.16M | -$19.73M | -$22.45M | -$16.33M | -22.4% |
| Net interest income | -$1.18M | $872.00K | $386.00K | -$81.00K | -234.7% |
| Pre-tax income | -$25.48M | -$18.90M | -$22.09M | -$16.43M | -34.8% |
| Tax provision | $55.00K | $12.00K | — | — | +358.3% |
| Net income | -$25.54M | -$18.91M | -$22.09M | -$16.43M | -35.0% |
| Net income to common | -$25.54M | -$18.91M | -$22.09M | -$16.43M | -35.0% |
| Basic EPS | -0.90 | -0.70 | -0.90 | -0.68 | -28.6% |
| Diluted EPS | -0.90 | -0.70 | -0.90 | -0.68 | -28.6% |
| EBIT | -$23.10M | -$18.38M | -$22.45M | -$16.35M | -25.6% |
| EBITDA | -$20.86M | -$16.48M | -$20.99M | -$15.58M | -26.6% |
| Basic shares | 28.32M | 27.03M | 24.61M | 24.18M | +4.8% |
| Diluted shares | 28.32M | 27.03M | 24.61M | 24.18M | +4.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $45.92M | $20.10M | $23.14M | $27.61M | — | +128.4% |
| Cash & short-term investments | $45.92M | $20.10M | $23.14M | $37.49M | — | +128.4% |
| Accounts receivable | $6.55M | $4.71M | $3.21M | $2.67M | — | +39.0% |
| Inventory | $8.36M | $6.86M | $7.91M | $9.30M | — | +21.8% |
| Total current assets | $63.60M | $33.36M | $36.17M | $51.18M | — | +90.6% |
| Property, plant & equipment | $11.05M | $5.09M | $4.95M | $2.70M | — | +117.1% |
| Goodwill & intangibles | $21.39M | $0 | $1.04M | $1.03M | — | — |
| Total assets | $97.75M | $39.19M | $42.66M | $55.49M | — | +149.4% |
| Total current liabilities | $10.77M | $10.35M | $7.43M | $6.79M | — | +4.0% |
| Long-term debt | $49.08M | — | $9.95M | $9.89M | $9.84M | — |
| Total debt | $58.23M | $3.57M | $13.94M | $11.99M | — | +1,532.1% |
| Total liabilities | $69.73M | $13.80M | $21.49M | $18.60M | — | +405.3% |
| Retained earnings | -$216.91M | -$191.37M | -$172.46M | -$150.37M | — | -13.3% |
| Shareholder equity | $28.02M | $25.39M | $21.17M | $36.89M | — | +10.4% |
| Working capital | $52.84M | $23.01M | $28.74M | $44.39M | — | +129.6% |
| Net tangible assets | $6.63M | $25.39M | $20.13M | $35.86M | — | -73.9% |
| Shares issued | 29.37M | 27.62M | 24.65M | 24.58M | — | +6.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$25.54M | -$18.91M | -$22.09M | -$16.43M | -35.0% |
| Depreciation & amortisation | $2.24M | $1.90M | $1.46M | $777.00K | +17.6% |
| Stock-based compensation | $8.18M | $6.91M | $6.08M | $4.13M | +18.4% |
| Change in working capital | -$9.81M | $1.40M | -$356.00K | -$4.29M | -801.5% |
| Operating cash flow | -$23.93M | -$8.95M | -$13.72M | -$16.17M | -167.3% |
| Capital expenditure | -$522.00K | -$275.00K | -$1.05M | -$1.15M | -89.8% |
| Investing cash flow | $615.00K | -$275.00K | $8.95M | -$10.74M | +323.6% |
| Financing cash flow | $50.18M | $6.19M | $296.00K | $409.00K | +710.8% |
| Free cash flow | -$24.45M | -$9.22M | -$14.77M | -$17.31M | -165.0% |
| End cash position | $46.97M | $20.10M | $23.14M | $27.61M | +133.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $10.88M | $12.13M | $10.41M | $8.86M | $9.21M | — | -10.3% |
| Operating revenue | $10.88M | $12.13M | $10.41M | $8.86M | $9.21M | — | -10.3% |
| Cost of revenue | $4.17M | $4.37M | $4.01M | $3.26M | $3.66M | — | -4.6% |
| Gross profit | $6.71M | $7.76M | $6.40M | $5.60M | $5.56M | — | -13.5% |
| Research & development | $4.63M | $4.52M | $3.24M | $3.45M | $3.83M | — | +2.4% |
| Selling, general & admin | $12.32M | $11.71M | $10.21M | $7.42M | $7.41M | — | +5.2% |
| Total operating expense | $16.95M | $16.23M | $13.45M | $10.88M | $11.24M | — | +4.4% |
| Operating income | -$10.24M | -$8.48M | -$7.04M | -$5.28M | -$5.68M | — | -20.8% |
| Net interest income | -$1.12M | -$1.03M | -$703.00K | -$543.00K | -$80.00K | — | -9.0% |
| Pre-tax income | -$11.38M | -$9.54M | -$7.78M | -$5.88M | -$5.81M | — | -19.2% |
| Tax provision | -$38.00K | $8.00K | $4.00K | $8.00K | $25.00K | — | -575.0% |
| Net income | -$11.34M | -$9.55M | -$7.79M | -$5.89M | -$5.84M | — | -18.7% |
| Net income to common | -$11.34M | -$9.55M | -$7.79M | -$5.89M | -$5.84M | — | -18.7% |
| Basic EPS | -0.38 | -0.32 | — | -0.21 | -0.21 | -0.22 | -18.8% |
| Diluted EPS | -0.38 | -0.32 | — | -0.21 | -0.21 | -0.22 | -18.8% |
| EBIT | -$9.96M | -$8.16M | -$5.87M | -$5.34M | -$5.45M | — | -22.1% |
| EBITDA | -$8.59M | -$7.05M | -$5.01M | -$4.91M | -$4.82M | — | -21.8% |
| Basic shares | 30.17M | 29.55M | — | 28.43M | 28.26M | 27.72M | +2.1% |
| Diluted shares | 30.17M | 29.55M | — | 28.43M | 28.26M | 27.72M | +2.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $29.36M | $35.59M | $45.92M | $38.22M | $41.54M | — | -17.5% |
| Cash & short-term investments | $29.36M | $35.59M | $45.92M | $38.22M | $41.54M | — | -17.5% |
| Accounts receivable | $8.39M | $8.66M | $6.55M | $4.00M | $4.26M | — | -3.1% |
| Inventory | $8.81M | $8.57M | $8.36M | $6.58M | $6.29M | — | +2.8% |
| Total current assets | $48.93M | $54.88M | $63.60M | $51.33M | $53.99M | — | -10.8% |
| Property, plant & equipment | $15.63M | $16.00M | $11.05M | $8.07M | $8.16M | — | -2.3% |
| Goodwill & intangibles | $20.39M | $20.89M | $21.39M | — | — | $565.00K | -2.4% |
| Total assets | $86.74M | $93.42M | $97.75M | $60.36M | $62.87M | — | -7.1% |
| Total current liabilities | $10.31M | $9.48M | $10.77M | $8.05M | $7.40M | — | +8.8% |
| Long-term debt | $50.23M | $49.64M | $49.08M | $29.20M | $28.84M | — | +1.2% |
| Total debt | $63.95M | $63.59M | $58.23M | $35.74M | $35.46M | — | +0.6% |
| Total liabilities | $75.97M | $74.58M | $69.73M | $44.48M | $43.13M | — | +1.9% |
| Retained earnings | -$237.80M | -$226.46M | -$216.91M | -$209.12M | -$203.23M | — | -5.0% |
| Shareholder equity | $10.78M | $18.84M | $28.02M | $15.87M | $19.74M | — | -42.8% |
| Working capital | $38.62M | $45.40M | $52.84M | $43.28M | $46.59M | — | -14.9% |
| Net tangible assets | -$9.61M | -$2.05M | $6.63M | $15.87M | $19.74M | — | -368.8% |
| Shares issued | 30.50M | 29.99M | 29.37M | 28.43M | 28.27M | — | +1.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$11.34M | -$9.55M | -$7.79M | -$5.89M | -$5.84M | -18.7% |
| Depreciation & amortisation | $1.37M | $1.11M | $851.00K | $426.00K | $626.00K | +23.5% |
| Stock-based compensation | $2.27M | $2.22M | $1.98M | $2.02M | $2.27M | +2.4% |
| Change in working capital | $122.00K | -$2.22M | -$7.37M | -$35.00K | $197.00K | +105.5% |
| Operating cash flow | -$7.01M | -$7.97M | -$12.08M | -$3.12M | -$2.55M | +11.9% |
| Capital expenditure | -$214.00K | -$645.00K | -$49.00K | -$199.00K | -$91.00K | +66.8% |
| Investing cash flow | -$214.00K | -$645.00K | $1.09M | -$199.00K | -$91.00K | +66.8% |
| Financing cash flow | $1.00M | -$1.84M | $19.56M | $0 | $31.98M | +154.3% |
| Free cash flow | -$7.23M | -$8.61M | -$12.13M | -$3.32M | -$2.64M | +16.1% |
| End cash position | $30.29M | $36.52M | $46.97M | $38.40M | $41.72M | -17.1% |
Options analytics
Put / call volume
0.30
Call-heavy session
Put / call open interest
0.13
Positioning, not flow
Max pain
15.00
+36.2% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-12.5%
Calls bid over puts
Call volume
179
Contracts, this expiry
Put volume
54
Contracts, this expiry
Heaviest call OI
20.00
4.41K contracts
Heaviest put OI
12.50
608 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.29 | -0.38 | -32.6% |
| Mar 2026 | -0.27 | -0.32 | -17.1% |
| Dec 2025 | -0.20 | -0.27 | -35.0% |
| Sep 2025 | -0.20 | -0.21 | -5.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.32 | 2 | $12.30M | +38.8% |
| Next quarter | -0.30 | 2 | $13.65M | +31.1% |
| Current year | -1.31 | 2 | $49.00M | +32.5% |
| Next year | -1.20 | 2 | $56.55M | +15.4% |
Analyst targets & ownership
Mean target$23.50
High target$25.00
Low target$22.00
Implied upside114.73%
Analyst count2
ConsensusSTRONG BUY
Strong buy / Buy0 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders5.48%
Held by institutions52.48%
Institutions holding182
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.86
-14.89% from price
SMA 20
13.35
-17.53% from price
SMA 50
14.26
-22.82% from price
SMA 100
14.57
-24.91% from price
SMA 200
13.38
-17.74% from price
EMA 12
12.56
-12.85% from price
EMA 26
13.41
-18.38% from price
EMA 50
13.97
-21.65% from price
RSI (14)
35.4
Neutral
MACD (12,26,9)
-0.85
Hist -0.33
ATR (14)
1.15
10.41% of price
Realised vol 30D
100.3%
Annualised
Bollinger upper
16.17
20, 2σ
Bollinger lower
10.53
20, 2σ
50 / 200 cross
Golden
14.26 vs 13.38
Trend bias
Below 200
-17.74%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.80
More volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
100.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-70.7%
Peak to trough
Max drawdown 5Y
-76.4%
Peak to trough
ATR 14
1.15
10.41% of price
Beta (reported)
1.29
5Y monthly, from filing
Short interest
Shares short
4.33M
Prior 4.50M
Change vs prior
-3.7%
Shorts covering
% of float
14.68%
Elevated
% of shares out
14.19%
Against total outstanding
Days to cover
7.7
Crowded exit
Float
26.28M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 18, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Mar 18, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Mar 5, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Apr 25, 25 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Apr 1, 25 | Stifel | MAINTAINED | Buy | Buy |
| Jan 28, 25 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jan 21, 25 | Lake Street | MAINTAINED | Buy | Buy |
| Aug 27, 24 | Lake Street | MAINTAINED | Buy | Buy |
| Mar 13, 24 | Stifel | MAINTAINED | Buy | Buy |
| Oct 24, 23 | Stifel | INITIATED | — | Buy |
| Aug 9, 23 | Lake Street | MAINTAINED | Buy | Buy |
| Mar 18, 21 | Lake Street | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay dateJul 27, 2016
Last split1:40
Split dateJul 27, 2016
SEC filings
Periodic Financial Reports
10-Q · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-05-21
Offering Registrations
S-8 · 2026-05-20
Periodic Financial Reports
10-Q · 2026-05-13
Annual Report to Shareholders
ARS · 2026-04-23
Proxy Statements
DEF 14A · 2026-04-10
Corporate Changes & Voting Matters
8-K · 2026-03-17
Offering Registrations
S-8 · 2026-02-09
Headlines
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
InvestorsHub · 8d ago
Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?
Zacks · 23d ago
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
Simply Wall St. · 33d ago
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
Motley Fool · 57d ago
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary
Moby · 64d ago
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks · 65d ago
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 65d ago
ClearPoint Neuro Q2 Earnings Call Highlights
MarketBeat · 65d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.